Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Gastric Cancer

  Free Subscription


29.06.2020

1 BMC Cancer
1 Br J Cancer
1 Eur J Surg Oncol
1 Gastroenterology
1 Gastrointest Endosc
1 J Surg Oncol
3 Lancet Oncol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. PENG Z, Guan Q, Luo J, Deng W, et al
    Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated beta-catenin degradation in gastric cancer.
    BMC Cancer. 2020;20:582.
    PubMed         Abstract available


    Br J Cancer

  2. KIM JH, Han KD, Lee JK, Kim HS, et al
    Correction: Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality.
    Br J Cancer. 2020 Jun 17. pii: 10.1038/s41416-020-0946.
    PubMed         Abstract available


    Eur J Surg Oncol

  3. ALYAMI M, Bonnot PE, Mercier F, Laplace N, et al
    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Eur J Surg Oncol. 2020 Jun 9. pii: S0748-7983(20)30495.
    PubMed         Abstract available


    Gastroenterology

  4. LOW JT, Christie M, Ernst M, Dumoutier L, et al
    Loss of NFKB1 Results in Expression of Tumor Necrosis Factor and Activation of STAT1 to Promote Gastric Tumorigenesis in Mice.
    Gastroenterology. 2020 Jun 19. pii: S0016-5085(20)34840.
    PubMed         Abstract available


    Gastrointest Endosc

  5. XU S, Tang X, Chai N, Linghu E, et al
    Different risk factors between early and late cancer recurrences in patients without additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer.
    Gastrointest Endosc. 2020;92:223-224.
    PubMed        


    J Surg Oncol

  6. JU MR, Wang SC, Zeh HJ, Porembka MR, et al
    Minimally invasive gastrectomy for cancer and anastomotic options.
    J Surg Oncol. 2020;122:49-60.
    PubMed         Abstract available


    Lancet Oncol

  7. KAWAZOE A, Fukuoka S, Nakamura Y, Kuboki Y, et al
    Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial.
    Lancet Oncol. 2020 Jun 23. pii: S1470-2045(20)30271.
    PubMed         Abstract available

  8. HERBST RS, Arkenau HT, Santana-Davila R, Calvo E, et al
    Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
    Lancet Oncol. 2019 Jul 10. pii: S1470-2045(19)30458.
    PubMed         Abstract available

  9. CASCINU S
    Lenvatinib and pembrolizumab in advanced gastric cancer.
    Lancet Oncol. 2020 Jun 23. pii: S1470-2045(20)30336.
    PubMed        


    PLoS One

  10. DALHAMMAR K, Malmstrom M, Schelin M, Falkenback D, et al
    The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study.
    PLoS One. 2020;15:e0235045.
    PubMed         Abstract available

  11. MORALES-ESPINOSA R, Delgado G, Serrano LR, Castillo E, et al
    High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.
    PLoS One. 2020;15:e0230220.
    PubMed         Abstract available

  12. TOKUHARA T, Nakata E, Tenjo T, Kawai I, et al
    Modified delta-shaped gastroduodenostomy consisting of linear stapling and single-layer suturing with the operator positioned between the patient's legs: A technique preventing intraoperative duodenal injury and postoperative anastomotic stenosis.
    PLoS One. 2020;15:e0230113.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: